First Mercantile Trust’s Sage Therapeutics SAGE Stock Holding History

First Mercantile Trust’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,086	Closed	-$295K	–	892
2019 Q4	$295K	Buy	4,086 +1,361	+50%	+$167K	0.03%	339
2019 Q3	$382K	Sell	2,725 -13	-0.5%	-$2.17K	0.04%	295
2019 Q2	$502K	Buy	2,738 +544	+25%	+$92.8K	0.05%	216
2019 Q1	$349K	Buy	2,194 +757	+53%	+$110K	0.08%	287
2018 Q4	$138K	Sell	1,437 -644	-31%	-$73.7K	0.03%	544
2018 Q3	$294K	Buy	2,081 +252	+14%	+$38.9K	0.06%	380
2018 Q2	$286K	Buy	1,829 +1,060	+138%	+$166K	0.06%	394
2018 Q1	$124K	Sell	769 -257	-25%	-$43.6K	0.03%	634
2017 Q4	$169K	Buy	+1,026	New	+$99.5K	0.03%	589

Other funds holding SAGE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

First Mercantile Trust's SAGE Position: Q1 2020 in Review

First Mercantile Trust sold out of Sage Therapeutics (SAGE) in Q1 2020, closing a stake of 4,086 shares — an estimated $295K sold.

First Mercantile Trust first reported a position in SAGE in Q4 2017 and held it in 9 quarters. The position peaked at $502K in Q2 2019. 230 funds tracked by Wall St. Rank hold SAGE as of Q1 2020.

First Mercantile Trust reported no remaining Sage Therapeutics position as of Q1 2020 after selling out during the quarter.
First Mercantile Trust sold 4,086 Sage Therapeutics shares in Q1 2020, an estimated $295K.
First Mercantile Trust first reported a position in Sage Therapeutics in Q4 2017 and held it in 9 quarters.
First Mercantile Trust's Sage Therapeutics position peaked at $502K in Q2 2019.
230 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2020.

Based on First Mercantile Trust's 13F filing for Q1 2020, filed 12 May 2020.